Learn about superficial spreading melanoma, from the ABCDE diagnostic rules to the latest in immunotherapy, targeted care and surgical options. Superficial spreading ...

Day One Biopharmaceuticals, Inc., now part of Servier Group, today announced that it has completed enrollment in the ...

Patient recounts IL‑2 therapy chills, rigors, ICU seizure scare, and recovery—what treatment feels like and why monitoring ...

Researchers compared outcomes of patients with colon cancer and hypertension taking RASIs in the first month after surgery ...

Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) Q1 net sales of $106.7 million, ...

Tumor fraction to improve patient selection for oncology early phase clinical trials: Analysis of two precision medicine studies. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I.

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...

Despite discontinuing an early-stage program, the firm remains committed to growing through internal programs like Padcev, ...

Investigators analyzed the immune-modulatory cancer vaccine IO102-IO103 plus pembrolizumab for PFS in patients with untreated advanced melanoma.

Clinical outcomes and safety of adjuvant therapy in patients with high-risk melanoma harboring BRAF V600 mutations: A multicenter, retrospective cohort study. Lymphatic mapping to the inguinal region ...